Literature DB >> 12395087

Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex.

Hong Qu Yan1, Anthony E Kline, Xiecheng Ma, Youming Li, C Edward Dixon.   

Abstract

Disturbances in dopamine neurotransmission contribute to frontal lobe dysfunction after traumatic brain injury. The changes in dopamine neurotransmission may be mediated by alterations in the dopamine transporter, which plays a key role in maintaining dopamine homeostasis. To determine whether the dopamine transporter system is altered after traumatic brain injury, dopamine transporter protein was examined bilaterally in the rat frontal cortex by Western blot at 1, 7, and 28 days after controlled cortical impact or sham injury ( = 6/group). Dopamine transporter protein expression was decreased in the injured (ipsilateral) cortex at 7 days and bilaterally at 28 days in injured sham control rats. The decrease in dopamine transporter protein levels may reflect a traumatic brain-injury-induced down-regulation of dopamine transporter and/or a loss of dopaminergic fibers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395087     DOI: 10.1097/00001756-200210280-00013

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  29 in total

1.  Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma.

Authors:  Anthony E Kline; Jaime L Massucci; Roos D Zafonte; C Edward Dixon; Judith R DeFeo; Emily H Rogers
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

2.  Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus.

Authors:  Samuel S Shin; Hong Q Yan; Xiecheng Ma; Youming Li; C Edward Dixon
Journal:  Brain Res       Date:  2013-12-31       Impact factor: 3.252

3.  Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes.

Authors:  Michelle D Failla; John M Myrga; Joseph H Ricker; C Edward Dixon; Yvette P Conley; Amy K Wagner
Journal:  J Head Trauma Rehabil       Date:  2015 Nov-Dec       Impact factor: 2.710

4.  Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats.

Authors:  Samuel S Shin; Eric R Bray; C Edward Dixon
Journal:  J Neurotrauma       Date:  2011-10-24       Impact factor: 5.269

5.  Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits.

Authors:  Ann N Hoffman; Jeffrey P Cheng; Ross D Zafonte; Anthony E Kline
Journal:  Life Sci       Date:  2008-08-31       Impact factor: 5.037

6.  Traumatic brain injuries during development disrupt dopaminergic signaling.

Authors:  Kate Karelina; Kristopher R Gaier; Zachary M Weil
Journal:  Exp Neurol       Date:  2017-08-09       Impact factor: 5.330

7.  A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.

Authors:  S Edut; V Rubovitch; M Rehavi; S Schreiber; C G Pick
Journal:  J Mol Neurosci       Date:  2014-08-16       Impact factor: 3.444

8.  Environmental enrichment as a viable neurorehabilitation strategy for experimental traumatic brain injury.

Authors:  Corina O Bondi; Kyle C Klitsch; Jacob B Leary; Anthony E Kline
Journal:  J Neurotrauma       Date:  2014-04-17       Impact factor: 5.269

Review 9.  Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.

Authors:  Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline
Journal:  Neurosci Biobehav Rev       Date:  2014-12-10       Impact factor: 8.989

Review 10.  5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.

Authors:  Jeffrey P Cheng; Jacob B Leary; Aerin Sembhi; Clarice M Edwards; Corina O Bondi; Anthony E Kline
Journal:  Brain Res       Date:  2015-11-21       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.